Full Text
POSB283 Approaches for Cost-Effectiveness Analyses in Adjuvant Oncology Indications and Their Acceptability By HTA Authorities

Abstract

Authors

S Ricci A Amadi N Varol S Teitsson JR May D Bertwistle

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×